Nicox was pleased to participate in the American Academy of Optometry (AAOpt) Annual Meeting 2026 with presentations highlighting key scientific data on NCX 470 and its potential in glaucoma and ocular hypertension. 

We would like to thank our presenters, Nora Cothran, OD, FAAO, and Siobhan Garbutt, PhD, Vice President and Head of Clinical Development, for sharing their expertise and helping communicate the scientific progress of the NCX 470 program with the optometric community.  They were joined by Doug Hubatsch, our Chief Scientific Advisor and Craig Sponseller, MD, Chief Medical Officer at our U.S. licensing partner, Kowa Pharmaceuticals America, Inc. 

As part of our ongoing commitment to engage with eye care professionals and keeping our shareholders informed, we are pleased to make the AAOPT 2026 presentation and poster available on our website, alongside our other scientific presentations. These materials can be accessed in the PUBLICATIONS section. 

We thank all attendees for their interest and for the valuable discussions during the meeting. A selection of photos from the event is included below.